Psoriasis Vulgaris Clinical Trials in San Francisco, California
2 recruitingSan Francisco, California
Showing 1–2 of 2 trials
Recruiting
Phase 4
Correction of Psoriatic T Cell Signatures by Deucravacitinib
Psoriasis Vulgaris
University of California, San Francisco25 enrolled1 locationNCT05858645
Recruiting
Phase 4
Psoriatic Immune Response to Tildrakizumab
Psoriasis Vulgaris
University of California, San Francisco10 enrolled1 locationNCT05390515